Artificial Intelligence in Cancer: A SWOT Analysis

Abstract

Cancer, a collection of maladies that has undergone extensive examination over centuries, remains a formidable challenge. Despite the array of available pharmacological and therapeutic interventions, the intricate molecular dynamics and heterogeneity of cancer continue to challenge the scientific community. Artificial Intelligence (AI) emerges as a promising avenue, offering the potential for expedited, precise diagnostics devoid of human expertise. Additionally, AI facilitates the tailoring of patient-specific therapeutic strategies targeting various facets of cancer, spanning macroscopic to microscopic levels. Nonetheless, it is imperative to scrutinize the potential benefits and limitations of AI technologies in this context. This review undertakes a comprehensive Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis of AI's application in cancer. An extensive compilation of AI applications encompasses predictive modeling, diagnostic capabilities, prognostic assessments, and personalized therapeutic modalities, spanning genomic analyses to individualized treatment regimens. The synthesis of evidence suggests that the advantages of AI outweigh its drawbacks; nevertheless, obstacles to its widespread integration persist.

Ähnliche Arbeiten